Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $565.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective upped by Robert W. Baird from $503.00 to $565.00 in a report issued on Thursday morning, Marketbeat Ratings reports. They currently have an outperform rating on the medical equipment provider’s stock.

A number of other equities research analysts have also recently commented on ISRG. Morgan Stanley raised their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Raymond James upped their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Piper Sandler increased their target price on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Finally, Truist Financial boosted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Trading Up 10.0 %

ISRG opened at $521.15 on Thursday. The company’s 50 day moving average is $483.85 and its 200 day moving average is $438.17. The company has a market cap of $184.85 billion, a price-to-earnings ratio of 94.07, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 12-month low of $254.85 and a 12-month high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. During the same quarter in the previous year, the firm posted $1.18 EPS. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical will post 5.22 EPS for the current fiscal year.

Insider Activity

In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,120 shares of company stock worth $25,528,753. 0.90% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently added to or reduced their stakes in the company. Ullmann Wealth Partners Group LLC boosted its position in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC lifted its stake in shares of Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after acquiring an additional 23 shares during the last quarter. Daymark Wealth Partners LLC boosted its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after acquiring an additional 24 shares during the period. Indiana Trust & Investment Management CO grew its position in Intuitive Surgical by 5.3% in the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after acquiring an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC grew its position in Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.